XML 47 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2019
Disclosure of Shareholder's Equity [Line Items]  
Disclosure of number and weighted average exercise prices of share options
The following table summarizes information about the stock options outstanding and exercisable:
 
    
 
Year ended December 31, 2019
 
   
 
Year ended December 31, 2018
 
 
 
  
 
 
Number of options
 
 
 
  
 
 
 
 
 
 
Weighted average
 
exercise price
 
 
 
 
 
 
  
 
 
 
 
 
Number of
 
options
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average
 
exercise price
 
 
 
 
 
 
Balance at beginning of the year
  
 
3,130,000
 
  
$
4.17
 
   3,640,000  $4.40 
Granted during the year
  
 
1,090,000
 
  
 
1.30
 
   240,000   3.30 
Expired/forfeited during the year
  
 
(701,665)
 
  
 
4.24
 
   (750,000)   5.00 
Balance at end of the year
  
 
3,518,335
 
  
$
3.26
 
   3,130,000  $4.17 
Options exercisable at the end of the year
  
 
1,972,223
 
  
$
4.32
 
   2,183,334  $4.45 
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period
The fair value of the stock options granted have been estimated on the date of grant using the Black-Scholes option pricing model. The assumptions are presented below for options granted during the December 31, 2018 and 2019 periods. Expected volatility is calculated by reference to the weekly closing share price for a period that reflects the expected life of the options. The 1,090,000 stock options issued on December 27, 2019 vest 1/3 on December 27, 2020, 1/3 on December 27, 2021 and 1/3 on December 27, 2022. The 200,000 stock options issued on June 30, 2018 vest 1/3 on July 1, 2019, 1/3 on July 1, 2020 and 1/3 on July 1, 2021. The 40,000 stock options issued on June 30, 2018 vest 1/2 on July 1, 2019 and 1/2 on July 1, 2020.
 
  
    
December 31,
 
2019
            
December 31,
 
2018
 
Exercise price
    
 
$                         1.30
 
                   $3.30 
Expected volatility
    
 
43.33%
 
         30.78% 
Expected option life
    
 
5 years
 
         5 years 
Contractual option life
    
 
5 years
 
         5 years 
Expected forfeiture
    
 
none
 
         none 
Expected option cancellation
    
 
none
 
         none 
Expected dividend yield
    
 
0%
 
         0% 
Risk-free interest rate
    
 
1.64%
 
    
 
 
 
     2.06% 
Disclosure of number and weighted average exercise prices of other equity instruments
The following table shows the RSU awards which have been granted and settled during the year:
 
    
December 31, 2019
 
   
December 31, 2018
 
 
RSU
 
  
Number of units
 
   
    Weighted average value
 
   
    Number of units
 
   
    Weighted average value
 
 
Balance at beginning of year
  
 
368,997
 
  
$
 5.01
 
   488,665   $ 4.88 
Awards and payouts during the period (net):
        
RSUs awarded
  
 
990,000
 
  
 
1.13
 
   -    - 
RSUs settled and common shares issued
  
 
(289,997)
 
  
 
5.35
 
   (111,668)    4.33 
RSUs forfeited
  
 
(4,000)
 
  
 
6.49
 
   (8,000)    6.49 
     
Balance at end of the year*
  
 
1,065,000
 
  
$
1.31
 
   368,997   $5.01 
*As at December 31, 2019, 16,667 RSUs (2018, 106,668 RSUs) at a weighted average value of $3.90 have vested and have not yet been settled.
Explanation of effect of share-based payments on entity's profit or loss
The share-based payments recognized as an expense for the years ended December 31, 2019 and 2018 are as follows:
 
    
Year ended
   Year ended 
    
December 31, 2019
           December 31, 2018 
Expense recognized in the period
for share-based payments
  
$
 789
   $ 1,685 
Earnings per share
The following table sets forth the computation of basic and diluted loss per share:

 
  
  
Year ended
 
December 31, 2019
 
  
Year ended
 
        December 31, 2018
 
Numerator
  
   
  
   
   
Net loss for the year
  
$
(128,758)
 
  
$
(18,934)
 
   
Denominator
  
   
  
   
   
For basic - weighted average number of shares outstanding
  
 
210,134,192
 
  
 
195,968,588
 
   
Effect of dilutive securities
  
 
-
 
  
 
-
 
   
For diluted - adjusted weighted average number of shares outstanding
  
 
210,134,192
 
  
 
195,968,588
 
   
Loss Per Share
  
   
  
   
Basic
  
$
(0.61)
 
  
$
(0.10)
 
Diluted
  
$
(0.61)
 
  
$
(0.10)
 
Black scholes [Member]  
Disclosure of Shareholder's Equity [Line Items]  
Disclosure of number and weighted average exercise prices of other equity instruments
The following tables reflect the number of stock options outstanding, the weighted average of options outstanding, and the exercise price of stock options outstanding at December 31, 2019. The Black-Scholes values are measured at the grant date.
 
At December 31, 2019
                
Expiry Date
  
Black-Scholes
 
Value
   
Number of
 
Options
   
Number of
 
Exercisable Options
   
Exercise
 
Price
 
April 13, 2020
   925    585,000    585,000    4.66 
October 14, 2020
   133    100,000    100,000    4.21 
December 10, 2020
   332    295,000    295,000    3.57 
June 30, 2021
   120    100,000    100,000    6.35 
November 3, 2021
   214    100,000    100,000    6.96 
February 5, 2022
   171    100,000    100,000    5.86 
December 21, 2022
   967    908,335    605,556    3.48 
June 30, 2023
   203    200,000    66,667    3.30 
June 30, 2023
   41    40,000    20,000    3.30 
December 27, 2024
   436    1,090,000    -    1.30 
     
 
  $                3,542    3,518,335    1,972,223   $        3.26